Legislative Advocacy

The FTC report exposes PBMs for inflating drug costs and harming independent pharmacies through unfair practices.

Finish the fight for PBM reform. Engage patients with resources to message their elected officials.

IPC and a coalition of pharmacy organizations released a statement before Tuesday's U.S. House Oversight hearing on PBM tactics.

FTC's July 2024 report reveals PBMs inflating drug costs, squeezing community pharmacies, and impacting patient access.

The FDA has announced critical updates on the implementation of the Drug Supply Chain Security Act (DSCSA).

IPC champions community pharmacies in pivotal Ohio case.

Transforming pharmacy benefits for better patient care. Learn how states are leading the charge.

IPC lobbies for policies to help community pharmacy during their recent fly-in to Washington D.C.

Getting involved with government relations doesn’t have to be complicated for pharmacy owners, IPC is here to help.

AB 317 empowers California pharmacists. IPC leads PBM reform advocacy. FDA mandates DSCSA compliance. Stay updated with critical healthcare news.